Authors:
BALDINI L
BLINI M
GUFFANTI A
FOSSATI V
COLOMBI M
LATARGIA ML
BERTONI F
ALIETTI A
NERI A
BERTONI G
Citation: L. Baldini et al., TREATMENT AND PROGNOSIS IN A SERIES OF PRIMARY EXTRANODAL LYMPHOMAS OF THE OCULAR ADNEXA, Annals of oncology, 9(7), 1998, pp. 779-781
Authors:
TOMIROTTI M
GALASSI B
DAMBROSIO M
FOSSATI V
GRAMEGNA G
COLOMBO F
ROVEJ R
SCANNI A
Citation: M. Tomirotti et al., CIS CARBOPLATIN PLUS VINORELBINE +/- RADIOTHERAPY IN STAGE-III AND STAGE-IV NON-SMALL-CELL LUNG-CARCINOMA/, Journal of chemotherapy, 9(1), 1997, pp. 62-65
Authors:
COMI G
RODEGHER M
COLOMBO B
MARTINELLI V
FOSSATI V
FILIPPI M
Citation: G. Comi et al., LOW-DOSE TOTAL-BODY IRRADIATION IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS - A DOUBLE-BLIND, CONTROLLED, RANDOMIZED PHASE-II STUDY, Neurology, 48(3), 1997, pp. 45004-45004
Authors:
LISSONI P
MEREGALLI S
NOSETTO L
BARNI S
TANCINI G
FOSSATI V
MAESTRONI G
Citation: P. Lissoni et al., INCREASED SURVIVAL-TIME IN BRAIN GLIOBLASTOMAS BY A RADIONEUROENDOCRINE STRATEGY WITH RADIOTHERAPY PLUS MELATONIN COMPARED TO RADIOTHERAPY ALONE, Oncology, 53(1), 1996, pp. 43-46
Authors:
VILLA S
PALAZZI M
ZANONI F
FOSSATI V
LEONARDI MC
MILANI F
Citation: S. Villa et al., THE ROLE OF TRANSRECTAL ULTRASOUND (TRUS) AND SERUM PSA FOR CLINICAL-EVALUATION OF RADICAL RADIOTHERAPY (RT) IN LOCALIZED PROSTATIC-CANCER, European journal of cancer, 31A, 1995, pp. 474-474
Authors:
LISSONI P
BARNI S
FOSSATI V
ARDIZZOIA A
CAZZANIGA M
TANCINI G
FRIGERIO F
Citation: P. Lissoni et al., A RANDOMIZED STUDY OF NEUROIMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN COMPARED TO SUPPORTIVE CARE ALONE IN PATIENTS WITH UNTREATABLE METASTATIC SOLID TUMOR, Supportive care in cancer, 3(3), 1995, pp. 194-197
Authors:
FOSSATI V
CATTANEO GM
ZERBI A
GALLI L
BORDOGNA G
RENI M
PAROLINI D
CARLUCCI M
BISSI A
STAUDACHER C
DICARLO V
CALANDRINO R
Citation: V. Fossati et al., THE ROLE OF INTRAOPERATIVE THERAPY BY ELECTRON-BEAM AND COMBINATION OF ADJUVANT CHEMOTHERAPY AND EXTERNAL RADIOTHERAPY IN CARCINOMA OF THE PANCREAS, Tumori, 81(1), 1995, pp. 23-31
Authors:
BARNI S
LISSONI P
CAZZANIGA M
ARDIZZOIA A
MEREGALLI S
FOSSATI V
FUMAGALLI L
BRIVIO F
TANCINI G
Citation: S. Barni et al., A RANDOMIZED STUDY OF LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN VERSUS SUPPORTIVE CARE ALONE IN METASTATIC COLORECTAL-CANCER PATIENTS PROGRESSING UNDER 5-FLUOROURACIL AND FOLATES, Oncology, 52(3), 1995, pp. 243-245
Authors:
LISSONI P
BARNI S
MEREGALLI S
FOSSATI V
CAZZANIGA M
ESPOSTI D
TANCINI G
Citation: P. Lissoni et al., MODULATION OF CANCER ENDOCRINE THERAPY BY MELATONIN - A PHASE-II STUDY OF TAMOXIFEN PLUS MELATONIN IN METASTATIC BREAST-CANCER PATIENTS PROGRESSING UNDER TAMOXIFEN ALONE, British Journal of Cancer, 71(4), 1995, pp. 854-856
Authors:
LISSONI P
ARDIZZOIA A
MEREGALLI S
BARNI S
FOSSATI V
BRIVIO F
TANCINI G
Citation: P. Lissoni et al., A CLINICAL-STUDY OF IMMUNOTHERAPY VERSUS ENDOCRINE THERAPY VERSUS CHEMOTHERAPY IN THE TREATMENT OF ADVANCED PANCREATIC ADENOCARCINOMA, Oncology Reports, 1(6), 1994, pp. 1277-1280
Authors:
LISSONI P
BARNI S
ARDIZZOIA A
FOSSATI V
PAOLOROSSI F
TANCINI G
Citation: P. Lissoni et al., WEEKLY EPIRUBICIN PLUS LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS THERAPY INBREAST-CANCER - PRELIMINARY IMMUNOBIOLOGICAL RESULTS, Journal of biological regulators and homeostatic agents, 8(2), 1994, pp. 53-55
Authors:
LISSONI P
BARNI S
ARDIZZOIA A
FOSSATI V
PAOLOROSSI F
TANCINI G
Citation: P. Lissoni et al., WEEKLY EPIRUBICIN PLUS LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS THERAPY INBREAST-CANCER - PRELIMINARY IMMUNOBIOLOGICAL RESULTS, Journal of biological regulators and homeostatic agents, 8(2), 1994, pp. 53-55
Authors:
LISSONI P
MEREGALLI S
FOSSATI V
PAOLOROSSI F
BARNI S
TANCINI G
FRIGERIO F
Citation: P. Lissoni et al., A RANDOMIZED STUDY OF IMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN VS CHEMOTHERAPY WITH CISPLATIN AND ETOPOSIDE CISPLATIN AND ETOPOSIDE AS FIRST-LINE, Tumori, 80(6), 1994, pp. 464-467
Authors:
ZERBI A
FOSSATI V
PAROLINI D
CARLUCCI M
BALZANO G
BORDOGNA G
STAUDACHER C
DICARLO V
Citation: A. Zerbi et al., INTRAOPERATIVE RADIATION-THERAPY ADJUVANT TO RESECTION IN THE TREATMENT OF PANCREATIC-CANCER, Cancer, 73(12), 1994, pp. 2930-2935
Authors:
LISSONI P
BARNI S
TANCINI G
BRIVIO F
CARDELLINI P
VAGHI M
FOSSATI V
FRIGERIO F
Citation: P. Lissoni et al., IMMUNOENDOCRINE THERAPY WITH INTERLEUKIN-2 (IL-2) AND MEDROXYPROGESTERONE ACETATE (MPA) - A RANDOMIZED STUDY WITH OR WITHOUT MPA IN METASTATIC RENAL-CANCER PATIENTS DURING IL-2 MAINTENANCE TREATMENT AFTER RESPONSE OR STABLE DISEASE TO IL-2 SUBCUTANEOUS THERAPY, Tumori, 79(4), 1993, pp. 246-249
Authors:
LISSONI P
MEREGALLI S
FOSSATI V
BARNI S
TANCINI G
BARIGOZZI P
FRIGERIO F
Citation: P. Lissoni et al., RADIOENDOCRINE THERAPY OF BRAIN-TUMORS WITH THE LONG-ACTING OPIOID ANTAGONIST NALTREXONE IN ASSOCIATION WITH RADIOTHERAPY, Tumori, 79(3), 1993, pp. 198-201
Authors:
TOMIROTTI M
GRAMEGNA G
MANTELLINI P
FOSSATI V
MEZZETTI M
DIMAIUTA M
SCANNI A
Citation: M. Tomirotti et al., CONCURRENT CARBOPLATIN (CBDCA), VINDESINE (VDS) AND RADIOTHERAPY IN STAGE-III NON-SMALL-CELL LUNG-CANCER (NSCLC), Tumori, 79(1), 1993, pp. 49-57
Authors:
FIORINO C
FOSSATI V
ARDESI A
CATTANEO GM
DELVECCHIO A
FUSCA M
LONGOBARDI B
SIGNOROTTO P
CALANDRINO R
Citation: C. Fiorino et al., DEVELOPMENT OF A COMPUTER-CONTROLLED MOVING BAR (CCMB) CONFORMAL TECHNIQUE FOR NECK IRRADIATION, Radiotherapy and oncology, 27(2), 1993, pp. 167-170